Delivery of medicinal products for dialysis treatment and solutions for peritoneal dialysis for the needs of UMBAL Dr. Georgi Stranski EAD – Pleven
Original notice title
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за диализно лечение и разтвори за перитонеално диализно лечение за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
70 / 100
Risk factors
Must hold specific authorizations (wholesale, production, narcotics) which can be time-consuming to obtain.
Tender documents and communications are in Bulgarian only.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- BGN 1.3M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of 26 pharmaceutical items for dialysis and peritoneal dialysis treatment.
- Delivery to UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria.
Show full summary
Supply of pharmaceutical products for dialysis treatment and peritoneal dialysis solutions for UMBAL Dr. Georgi Stranski EAD in Pleven, Bulgaria. The tender is a restricted procedure under a Dynamic Purchasing System (DPS) for 24 months, covering 26 items. Award based on lowest price.
Risks
Must hold specific authorizations (wholesale, production, narcotics) which can be time-consuming to obtain.
Tender documents and communications are in Bulgarian only.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Registration as a trader with wholesale authorization for medicinal products.
- Production authorization or manufacturer's authorization if applicable.
Certifications
- Narcotics license if tendering for products containing narcotic substances.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
гр. Плевен, BGR
Buyer profile
Identifier
114532352
Activity
Health
Lots (1)
LOT-0001
Delivery of medicinal products for dialysis treatment and solutions for peritoneal dialysis for the needs of UMBAL Dr. Georgi Stranski EAD – Pleven
Supply of 26 items of dialysis drugs and peritoneal dialysis solutions for the hospital in Pleven. The contract is for 24 months, with an estimated value of 1,266,280.29 BGN. Award criteria is lowest price.
BGN 1.3M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
На първо място се класира участникът, предложил най-ниска цена. Останалите оферти заемат места в класирането по низходящ ред
Value note
Show original TED data
Original lot title
„Доставка на лекарствени продукти за диализно лечение и разтвори за перитонеално диализно лечение за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – гр. Плевен
Original TED description
Процедура по реда на Закона за обществените поръчки за лекарствени продукти за диализно лечение и разтвори за перитонеално диализно лечение за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД - Плевен, по смисъла на Закона за лекарствените продукти в хуманната медицина, съгласно техническата спецификация и условията на настоящата документация. Процедурата включва 26 артикула.
Procurement Details
- Publication date
- 13 Jan 2025
- Languages
- Bulgarian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 25304-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
55 / 100
Complexity
70 / 100
Risk factors
Must hold specific authorizations (wholesale, production, narcotics) which can be time-consuming to obtain.
Tender documents and communications are in Bulgarian only.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications